RIG-I is a tumor suppressor and biomarker of IFN-α efficacy in HCC
- PMID: 24596206
- DOI: 10.1158/2159-8290.CD-RW2014-009
RIG-I is a tumor suppressor and biomarker of IFN-α efficacy in HCC
Abstract
RIG-I inhibits HCC carcinogenesis and enhances patient survival and IFN-α treatment response.
Comment on
-
Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma.Cancer Cell. 2014 Jan 13;25(1):49-63. doi: 10.1016/j.ccr.2013.11.011. Epub 2013 Dec 19. Cancer Cell. 2014. PMID: 24360797
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
